Although CpG oligodeoxynucleotides (ODNs) are useful vaccine adjuvants, optimizing these single-stranded synthetic DNAs to induce the desired immune response is tricky. This paper showed that K-class ODNs could be multimerized into stable nanorings using the HIV-derived peptide Tat. In mice, the nanorings boosted T helper 1 cell-mediated immune responses to a viral antigen, and produced good antitumour immunity when used as a therapeutic tumour vaccine adjuvant. So such ODN nanorings could be used as improved anticancer or antiviral vaccine adjuvants.